Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-04-19
2011-04-19
Saunders, David A (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S177100, C435S069600, C530S408000
Reexamination Certificate
active
07928205
ABSTRACT:
The present invention is generally directed to methods of producing an increase in the enrichment or recovery of preferred forms of IgG proteins. More particularly, the invention relates to subjecting preparations of such recombinant IgG proteins with a reduction/oxidation coupling reagent and optionally a chaotropic agent.
REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4737323 (1988-04-01), Martin et al.
patent: 4745051 (1988-05-01), Smith et al.
patent: 4766205 (1988-08-01), Ghosh-Dastidar
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4837028 (1989-06-01), Allen
patent: 4870009 (1989-09-01), Evans et al.
patent: 4952496 (1990-08-01), Studier et al.
patent: 5169784 (1992-12-01), Summers et al.
patent: 5225539 (1993-07-01), Winter
patent: 5242687 (1993-09-01), Tykocinski et al.
patent: 5243041 (1993-09-01), Fernandez-Pol
patent: 5266317 (1993-11-01), Tomalski et al.
patent: 5272071 (1993-12-01), Chappel
patent: 6036978 (2000-03-01), Gombotz et al.
patent: 6063905 (2000-05-01), Capra et al.
patent: 7157557 (2007-01-01), Sassenfeld et al.
patent: 2002/0182665 (2002-12-01), Sassenfeld et al.
patent: 2003/0023586 (2003-01-01), Knorr
patent: 2003/0138421 (2003-07-01), van de Winkel et al.
patent: 2004/0071702 (2004-04-01), van de Winkel et al.
patent: 2005/0101016 (2005-05-01), McIntyre
patent: 2005/0260681 (2005-11-01), McIntyre
patent: 2007/0082367 (2007-04-01), Godavarti et al.
patent: 2066370 (1996-04-01), None
patent: 0 120 694 (1984-10-01), None
patent: 0 125 023 (1984-11-01), None
patent: 0 194 276 (1986-09-01), None
patent: 0 239 400 (1987-09-01), None
patent: 0 293 785 (1988-12-01), None
patent: 0 451 216 (1991-10-01), None
patent: 0510658 (1992-10-01), None
patent: 0 519 596 (1992-12-01), None
patent: 0 553 494 (1993-08-01), None
patent: WO-86/01533 (1986-03-01), None
patent: WO-93/08207 (1993-04-01), None
patent: WO-94/22902 (1994-10-01), None
patent: WO-95/32216 (1995-11-01), None
patent: WO-96/03141 (1996-02-01), None
patent: WO-96/40918 (1996-12-01), None
patent: WO-01/34638 (2001-05-01), None
patent: WO-01/49720 (2001-07-01), None
patent: WO-02/068455 (2002-09-01), None
patent: WO-02/072636 (2002-09-01), None
patent: WO-03/000014 (2003-01-01), None
patent: WO-2005/073732 (2005-08-01), None
Zhang et al., BioProcessing Journal, p. 37-43 (2003).
International Search Report for PCT/US05/38045 issued on Apr. 20, 2007.
Zhang et al., Biotechnol. Prog., 18:509-513 (2002).
Aalberse et al., Immunology, 105:9-19 (2002).
Angel et al., Mol. Immunol., 30(1):105-108 (1993).
Bondarenko et al., Int. J. Mass Spectrom., 219:671-680 (2002).
Brasel et al., Blood, 88(6):2004-2012 (1996).
Buchner et al., Biochemistry, 30:6922-6929 (1991).
Buchner et al., J. Mol. Biol., 318:829-836 (2002).
Buchwald, Can. J. Biochem., 49:900-902 (1971).
Chaderjian et al., Biotechnol. Prog., 21:550-553 (2005).
Chaudhary et al., Nature, 339:394-397 (1989).
Chowdhury et al., Anal. Chem., 63:1660-1664 (1991).
Cohen, Annu. Rev. Biochem., 37:695-726 (1968).
Craescu et al., J. Biol. Chem., 261(31):14710-14716 (1986).
Creighton, Methods Enzymol., 107:305-329 (1984).
Davis et at., Biochemistry, 35:2482-2488 (1996).
Dillon et al., J. Chromatogr. A, 1053:299-305 (2004).
Dobo et al., Anal. Chem., 73(20):4763-4773 (2001).
Dormann et al., J. Biol. Chem., 268(22):16286-16292 (1993).
Fenn, J. Am. Soc. Mass. Specrom., 4:524-535 (1993).
Gregory et al., Mol. Immunol., 24(8):821-829 (1987).
Harris et al., J. Mol. Biol., 275(5):861-872 (1998).
Harris et al., Nature, 360:369-372 (1992).
Houee-Levin, Methods Enzymol., 353:35-44 (2002).
Houry et al., Nature, 402:147-154 (1999).
Hulett et al., Adv. Immunol., 57:1-127 (1994).
Jefferis et al., Immunol. Lett., 82:57-65 (2002).
Josic et al., Food Technol. Biotechnol., 39(3):215-226 (2001).
Kaufman et al., J. Biol. Chem., 263(13):6352-6362 (1988).
Keown et al., Methods Enzymol., 185:527-537 (1990).
Kuwajima, Proteins, 6:87-103 (1989).
Larrick et al., Biotechnology, 7:934-938 (1989).
Larson et al., J. Mol. Biol., 222:17-19 (1991).
Lilie et al., Curr. Opin. Biotechnol., 9:497-501 (1998).
Lilie et al., FEBS Lett., 362:43-46 (1995).
Lilie et al., J. Mol. Biol., 248:190-201 (1995).
Lilie et al., Protein Sci., 2:1490-1496 (1993).
Lilie et al., Protein Sci., 4:917-924 (1995).
Lim et al., Anal. Biochem., 295:45-56 (2001).
McKinnon et al., J. Mol. Endocrinol., 6:231-239 (1991).
Middelberg, Trends Biotechnol., 20(10):437-443 (2002).
Nakamura et al., Cell, 18:1109-1117 (1979).
Pace, Methods Enzymol., 131:266-280 (1986).
Perczel et al., Protein Eng., 4(6):669-679 (1991).
Phillips et al., Mol. Immunol., 31(15):1201-1210 (1994).
Ptitsyn et al., FEBS Lett., 262(1):20-24 (1990).
Rattenholl et al., Eur. J. Biochem., 268:3296-3303 (2001).
Riechmann et al., Nature, 332:323-327 (1988).
Ritz et al., Annu. Rev. Microbiol., 55:21-48 (2001).
Roberts et al., Nature, 328:731-734 (1987).
Rudolph et al., FASEB J., 10:49-56 (1996).
Saphire et al., J. Mol. Biol., 319:9-18 (2002).
Saphire et al., Science, 293:1155-1159 (2001).
Schauenstein et al., Int. Arch. Allergy Appl. Immunol., 80:174-179 (1986).
Schuurman et al., Immunology, 97:693-698 (1999).
Schuurman et al., Mol. Immunol., 38(1):1-8 (2001).
Seefeldt et al., Protein Sci., 13:2639-2650 (2004).
Segal et al., Proc. Natl. Acad. Sci. USA, 96:2758-2763 (1999).
St. John et al., Proc. Natl. Acad. Sci. USA, 96(23):13029-13033 (1999).
Studier et al., Methods Enzymol., 185:60-89 (1990).
Turner et al., Biochem. J., 107:171-178 (1968).
Umetsu et al., J. Biol. Chem., 278(11):8979-8987 (2003).
Urlaub et al., Proc. Natl. Acad. Sci. USA, 77(7):4216-4220 (1980).
Verhoeyen et al., Science, 239(4847):1534-1536 (1988).
von Heijne, J. Mol. Biol., 184:99-105 (1985).
Welfle et al., Biochim. Biophys. Acta, 1431:120-131 (1999).
Wood et al., J. Immunol., 145(9):3011-3016 (1990).
Wunderlich et al., J. Biol. Chem., 268(33):24547-24550 (1993).
Yoo et al., J. Immunol., 170:3134-3138 (2003).
Dillon et al., Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.J. Biol. Chem. 283(23):16206-15 (2008).
Banks et al., Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity.J. Pharmaceut. Sci. 97(2): 764-9 (2008).
Guo et al., Electrophoretic evidence for the presence of structural isoforms specific for the IgG2 isotype.Electrophoresis. 29: 2550-6 (2008).
McIntyre et al., Panitumumab. Oncolytic—anti-EGFR human monoclonal antibody.Drugs of the Future. 29(8): 793-7 (2004).
Supplementary European Search Report, EP 05 81 1874, dated Aug. 10, 2009.
Banks Douglas D.
Bondarenko Pavel
Dillon Thomas M.
Gadgil Himanshu S.
Goetze Andrew
Amgen Inc.
Saunders David A
Sholtz Charles K.
LandOfFree
Methods for refolding of recombinant antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for refolding of recombinant antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for refolding of recombinant antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2629293